CCND1 and neoplasm: Accordingly, 1,25(OH)2D3 reduced the expression of β-catenin target genes associated with tumour progression such as MYC (Myelocytomatosis) and CCND1 (encoding Cyclin D1) (Figure 1F, and Supplementary Figure S1F).